Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Smedby KE"" wg kryterium: Autor


Czasopismo naukowe
Tytuł:
Population-based study of patients with primary Sjögren's syndrome and lymphoma: lymphoma subtypes, clinical characteristics, and gender differences.
Autorzy:
Vasaitis, L
Nordmark, G
Theander, E
Backlin, C
Smedby, KE
Askling, J
Rönnblom, L
Sundström, C
Baecklund, E
Smedby, K E
Pokaż więcej
Temat:
LYMPHOID tissue
MUCOSA-associated lymphoid tissue lymphoma
CANCER diagnosis
SALIVARY glands
GENDER
SYNDROMES
SJOGREN'S syndrome diagnosis
SALIVARY gland tumors
TIME
B cell lymphoma
PLASMACYTOMA
CASE-control method
AGE factors in disease
SJOGREN'S syndrome
DEMOGRAPHY
MULTIPLE myeloma
LYMPHOMAS
EPSTEIN-Barr virus diseases
Źródło:
Scandinavian Journal of Rheumatology; May2020, Vol. 49 Issue 3, p225-232, 8p, 2 Charts
Terminy geograficzne:
SWEDEN
Czasopismo naukowe
Tytuł:
Comparison of patients with and without pre-existing lymphoma at diagnosis of primary Sjögren's syndrome.
Autorzy:
Vasaitis, L
Nordmark, G
Theander, E
Backlin, C
Smedby, KE
Askling, J
Rönnblom, L
Sundström, C
Baecklund, E
Smedby, K E
Pokaż więcej
Temat:
MUCOSA-associated lymphoid tissue lymphoma
SJOGREN'S syndrome
SJOGREN'S syndrome diagnosis
LYMPHOMAS
COMORBIDITY
SYMPTOMS
LYMPHOMA diagnosis
Źródło:
Scandinavian Journal of Rheumatology; May2019, Vol. 48 Issue 3, p207-212, 6p, 2 Charts
Czasopismo naukowe
Tytuł:
Anti-cyclic citrullinated peptide antibodies, other common autoantibodies, and smoking as risk factors for lymphoma in patients with rheumatoid arthritis.
Autorzy:
Baecklund, E
Backlin, C
Rönnelid, J
Toes, R
Huizinga, TWJ
Åhlin, E
Askling, J
Hochberg, FH
Klareskog, L
Kay, J
Smedby, KE
Hochberg, F H
Smedby, K E
Pokaż więcej
Temat:
RHEUMATOID arthritis
LYMPHOMAS
PEPTIDES
AUTOANTIBODIES
IMMUNOGLOBULIN G
Źródło:
Scandinavian Journal of Rheumatology; Jul2018, Vol. 47 Issue 4, p270-275, 6p, 3 Charts
Czasopismo naukowe
Tytuł:
Prevalence and predictors for fertility-related distress among 1010 young adults 1.5 years following cancer diagnosis - results from the population-based Fex-Can Cohort study.
Autorzy:
Rodriguez-Wallberg KA; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.; Department of Reproductive Medicine, Division of Gynecology and Reproduction, Karolinska University Hospital, Stockholm, Sweden.
Ahlgren J; Department of Oncology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.; Regional Cancer Centre, Mid-Sweden, Uppsala, Sweden.
Smedby KE; Department of Medicine Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden.; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
Gorman JR; College of Public Health and Human Sciences, Oregon State University, Corvallis, OR, USA.
Hellman K; Department of Gynecologic Cancer, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.
Henriksson R; Department of Radiation Science and Oncology, Umeå University, Umeå, Sweden.
Ståhl O; Department of Oncology, Skåne University Hospital, Lund, Sweden.
Wettergren L; Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Lampic C; Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.; Department of Psychology, Umeå University, Umeå, Sweden.
Pokaż więcej
Źródło:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2023 Dec; Vol. 62 (12), pp. 1599-1606. Date of Electronic Publication: 2023 Nov 25.
Typ publikacji:
Journal Article
MeSH Terms:
Infertility*
Fertility Preservation*/methods
Testicular Neoplasms*
Male ; Child ; Humans ; Female ; Young Adult ; Adult ; Cohort Studies ; Prevalence ; Fertility
Czasopismo naukowe
Tytuł:
The BioLymph study - implementing precision medicine approaches in lymphoma diagnostics, treatment and follow-up: feasibility and first results.
Autorzy:
Smedby KE; Dept of Hematology, Karolinska University Hospital Solna, Sweden.; Dept of Medicine Solna, div of Clinical Epidemiology, Karolinska Institutet, Stockholm, Sweden.
Wästerlid T; Dept of Hematology, Karolinska University Hospital Solna, Sweden.; Dept of Medicine Solna, div of Clinical Epidemiology, Karolinska Institutet, Stockholm, Sweden.
Tham E; Dept of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Dept of Clinical Genetics, Karolinska University Hospital Solna, Stockholm, Sweden.
Haider Z; Dept of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Joelsson J; Dept of Hematology, Karolinska University Hospital Solna, Sweden.; Dept of Medicine Solna, div of Clinical Epidemiology, Karolinska Institutet, Stockholm, Sweden.
Thorvaldsdottir B; Dept of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Krstic A; Dept of Clinical Genetics, Karolinska University Hospital Solna, Stockholm, Sweden.
Wahlin BE; Dept of Hematology, Karolinska University Hospital Solna, Sweden.; Dept of Medicine Huddinge, Karolinska Institutet.
Foroughi-Asl H
Karlsson C; Dept of Hematology, Karolinska University Hospital Solna, Sweden.; Dept of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Eloranta S; Dept of Medicine Solna, div of Clinical Epidemiology, Karolinska Institutet, Stockholm, Sweden.
Saft L; Dept of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Palma M; Dept of Hematology, Karolinska University Hospital Solna, Sweden.; Dept of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Kwiecinska A; Dept of Clinical Pathology and Cancer Diagnostics, Karolinska University Laboratory, Solna and Huddinge, Sweden.
Hansson L; Dept of Hematology, Karolinska University Hospital Solna, Sweden.; Dept of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Österborg A; Dept of Hematology, Karolinska University Hospital Solna, Sweden.; Dept of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Wirta V; Science for Life Laboratory, Dept of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.; Science for Life Laboratory, Royal Insititute of Technology, Stockholm, Sweden.; Genomic Medicine Center Karolinska, Karolinska University Hospital, Stockholm, Sweden.
Rassidakis G; Dept of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.; Dept of Clinical Pathology and Cancer Diagnostics, Karolinska University Laboratory, Solna and Huddinge, Sweden.
Sander B; Dept of Clinical Pathology and Cancer Diagnostics, Karolinska University Laboratory, Solna and Huddinge, Sweden.; Dept of Laboratory Medicine, Karolinska Institutet Stockholm, Sweden.
Sonnevi K; Dept of Hematology, Karolinska University Hospital Solna, Sweden.; Dept of Medicine Huddinge, Karolinska Institutet.
Rosenquist R; Dept of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Dept of Clinical Genetics, Karolinska University Hospital Solna, Stockholm, Sweden.; Genomic Medicine Center Karolinska, Karolinska University Hospital, Stockholm, Sweden.
Pokaż więcej
Źródło:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2023 Jun; Vol. 62 (6), pp. 560-564. Date of Electronic Publication: 2023 Jul 06.
Typ publikacji:
Journal Article
MeSH Terms:
Precision Medicine*/methods
Lymphoma*/diagnosis
Lymphoma*/genetics
Lymphoma*/therapy
Humans ; Feasibility Studies
Czasopismo naukowe
Tytuł:
CRCBaSe: a Swedish register-based resource for colorectal adenocarcinoma research.
Autorzy:
Weibull CE; Department of Medicine Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden.
Boman SE; Department of Medicine Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden.
Glimelius B; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Syk I; Department of Surgery, Skåne University Hospital, Malmö, Sweden.
Matthiessen P; Department of Surgery, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Smedby KE; Department of Medicine Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden.
Nordenvall C; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Pelvic Cancer, GI Oncology and Colorectal Surgery Unit, Karolinska University Hospital, Stockholm, Sweden.
Martling A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Pelvic Cancer, GI Oncology and Colorectal Surgery Unit, Karolinska University Hospital, Stockholm, Sweden.
Pokaż więcej
Źródło:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2023 Apr; Vol. 62 (4), pp. 342-349. Date of Electronic Publication: 2023 Apr 08.
Typ publikacji:
Journal Article
MeSH Terms:
Colorectal Neoplasms*/pathology
Adenocarcinoma*/epidemiology
Adenocarcinoma*/therapy
Child ; Humans ; Female ; Sweden/epidemiology ; Registries
Czasopismo naukowe
Tytuł:
Do young adults with cancer receive information about treatment-related impact on sex life? Results from a population-based study.
Autorzy:
Bergström C; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.; Department of Surgery and Urology, Danderyd Hospital, Stockholm, Sweden.
Lampic C; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.; Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.; Department of Psychology, Umeå University, Umeå, Sweden.
Roy R; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.; Department of Urology, Karolinska University Hospital, Huddinge, Sweden.
Hedman C; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; R&D Department, Stockholms Sjukhem Foundation, Stockholm, Sweden.; Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
Ahlgren J; Department of Oncology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.; Regional Cancer Center, Mid-Sweden, Uppsala, Sweden.
Ståhl O; Department of Oncology, Skåne University Hospital, Lund, Sweden.
Smedby KE; Department of Medicine Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden.; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
Hellman K; Department of Gynecologic Cancer, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.
Henriksson R; Department of Radiation Science and Oncology, University Hospital, Umeå, Sweden.
Eriksson LE; Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden.; School of Health and Psychological Sciences, City, University of London, London, UK.; Medical Unit Infectious Diseases, Karolinska University Hospital, Huddinge, Sweden.
Wettergren L; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.; Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Apr; Vol. 12 (8), pp. 9893-9901. Date of Electronic Publication: 2023 Feb 07.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Testicular Neoplasms*
Sexual Health*
Brain Neoplasms*/epidemiology
Brain Neoplasms*/therapy
Male ; Humans ; Female ; Young Adult ; Adult ; Cross-Sectional Studies ; Sexual Behavior
Czasopismo naukowe
Tytuł:
Prevalence and risk factors for sexual dysfunction in young women following a cancer diagnosis - a population-based study.
Autorzy:
Wettergren L; Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Eriksson LE; Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden.; School of Health and Psychological Sciences, City, University of London, London, United Kingdom.; Medical Unit Infectious Diseases, Karolinska University Hospital, Huddinge, Sweden.
Bergström C; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.; Department of Surgery and Urology, Danderyd University Hospital, Sweden.
Hedman C; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; R & D department, Stockholms Sjukhem Foundation, Stockholm, Sweden.; Division of Palliative Care, Department of Clinical Sciences Lund, Lund University, Sweden.
Ahlgren J; Department of Oncology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.; Regional cancer centre, Mid-Sweden, Uppsala, Sweden.
Smedby KE; Department of Medicine Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden.; Center for Hematology, Karolinska University Hospital, Stockholm, Sweden.
Hellman K; Department of Gynecologic Cancer, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.
Henriksson R; Department of Radiation Science and Oncology, University Hospital, Umeå, Sweden.
Lampic C; Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.; Department of Psychology, Umeå University, Umeå, Sweden.
Pokaż więcej
Źródło:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2022 Oct; Vol. 61 (10), pp. 1165-1172. Date of Electronic Publication: 2022 Sep 29.
Typ publikacji:
Journal Article
MeSH Terms:
Sexual Dysfunction, Physiological*/epidemiology
Sexual Dysfunction, Physiological*/etiology
Breast Neoplasms*/complications
Breast Neoplasms*/epidemiology
Breast Neoplasms*/therapy
Humans ; Female ; Prevalence ; Cross-Sectional Studies ; Sexual Behavior/psychology ; Risk Factors
Czasopismo naukowe
Tytuł:
Beta-blocker use and urothelial bladder cancer survival: a Swedish register-based cohort study.
Autorzy:
Udumyan R; Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden.
Botteri E; Department of Research, Cancer Registry of Norway, Oslo, Norway.; Section for Colorectal Cancer Screening, Cancer Registry of Norway, Oslo, Norway.
Jerlstrom T; Department of Urology, School of Health and Medical Sciences, Örebro University, Örebro, Sweden.
Montgomery S; Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden.; Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden.; Department of Epidemiology and Public Health, University College London, London, UK.
Smedby KE; Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden.; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
Fall K; Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden.; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Pokaż więcej
Źródło:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2022 Aug; Vol. 61 (8), pp. 922-930. Date of Electronic Publication: 2022 Jul 26.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Transitional Cell*/drug therapy
Urinary Bladder Neoplasms*/drug therapy
Adrenergic beta-Antagonists/therapeutic use ; Cohort Studies ; Humans ; Retrospective Studies ; Sweden/epidemiology
Czasopismo naukowe
Tytuł:
Cancer in young adulthood - classifying the intensity of treatment.
Autorzy:
Hedman C; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; R & D Department, Stockholms Sjukhem Foundation, Stockholm, Sweden.; Division of Palliative Care, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
Ahlgren J; Department of Oncology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.; Regional Cancer Centre, Uppsala-Örebro, Uppsala, Sweden.
Smedby KE; Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.; Center for Hematology, Karolinska University Hospital, Stockholm, Sweden.
Hellman K; Department of Gynecologic Cancer, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.
Henriksson R; Department of Radiation Science and Oncology, University Hospital, Umeå, Sweden.
Ståhl O; Department of Oncology, Skåne University Hospital, Lund, Sweden.
Wettergren L; Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Lampic C; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.; Department of Psychology, Umeå University, Umeå, Sweden.
Pokaż więcej
Źródło:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2022 Jul; Vol. 61 (7), pp. 809-813. Date of Electronic Publication: 2022 May 15.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasms*/therapy
Adult ; Age Factors ; Humans ; Young Adult
Czasopismo naukowe
Tytuł:
Identifying patients with chronic lymphocytic leukemia without need of treatment: End of endless watch and wait?
Autorzy:
Brieghel C; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
Galle V; Department of Clinical Hematology, Ghent University Hospital, Ghent, Belgium.
Agius R; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
da Cunha-Bang C; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
Andersen MA; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
Vlummens P; Department of Clinical Hematology, Ghent University Hospital, Ghent, Belgium.
Mattsson M; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.; Department of Hematology, Uppsala University Hospital, Uppsala, Sweden.
Rosenquist R; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Clinical Genetics, Karolinska University Laboratory, Karolinska University Hospital, Stockholm, Sweden.
Smedby KE; Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
Herling CD; Department of Internal Medicine, Uniklinik Köln, Cologne, Germany.
Bahlo J; Department of Internal Medicine, Uniklinik Köln, Cologne, Germany.
Hallek M; Department of Internal Medicine, Uniklinik Köln, Cologne, Germany.
Lundgren JD; Centre for Health, Immunity and Infectious Diseases (CHIP), Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Department of Clinical Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Offner F; Department of Clinical Hematology, Ghent University Hospital, Ghent, Belgium.
Niemann CU; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
Pokaż więcej
Źródło:
European journal of haematology [Eur J Haematol] 2022 May; Vol. 108 (5), pp. 369-378. Date of Electronic Publication: 2022 Jan 22.
Typ publikacji:
Journal Article
MeSH Terms:
Leukemia, Lymphocytic, Chronic, B-Cell*/diagnosis
Leukemia, Lymphocytic, Chronic, B-Cell*/genetics
Leukemia, Lymphocytic, Chronic, B-Cell*/therapy
Aged ; Chromosome Aberrations ; Humans ; Mutation ; Prognosis ; Risk Factors
Czasopismo naukowe
Tytuł:
Overall survival and registration of cutaneous T-cell lymphoma patients in Sweden: a multi-center cohort and validation study.
Autorzy:
Nenonen J; Division of Rheumatology, Department of Medicine, Solna and Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
Winther AH; Division of Rheumatology, Department of Medicine, Solna and Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.; Dermato-Venereology Clinic, Karolinska University Hospital, Stockholm, Sweden.
Leijonhufvud E; Division of Rheumatology, Department of Medicine, Solna and Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.; Dermato-Venereology Clinic, Uppsala Academic University Hospital, Uppsala, Sweden.
Belfrage E; Dermato-Venereology Clinic, Skåne university hospital, Lund, Sweden.; Department of Clinical Sciences, Lund University, Lund, Sweden.
Smedby KE; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, and Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
Brauner H; Division of Rheumatology, Department of Medicine, Solna and Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.; Dermato-Venereology Clinic, Karolinska University Hospital, Stockholm, Sweden.
Pokaż więcej
Źródło:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2022 May; Vol. 61 (5), pp. 597-601. Date of Electronic Publication: 2022 Mar 25.
Typ publikacji:
Letter; Multicenter Study
MeSH Terms:
Lymphoma, T-Cell, Cutaneous*/epidemiology
Lymphoma, T-Cell, Cutaneous*/pathology
Skin Neoplasms*/pathology
Cohort Studies ; Humans ; Retrospective Studies ; Sweden/epidemiology
Raport
Tytuł:
NSAID use and unnatural deaths after cancer diagnosis: a nationwide cohort study in Sweden.
Autorzy:
Shen Q; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, SE-171 77, Stockholm, Sweden. .
Sjölander A; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, SE-171 77, Stockholm, Sweden.
Sloan EK; Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, 5052, Australia.
Walker AK; Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, 5052, Australia.; Laboratory of ImmunoPsychiatry, Neuroscience Research Australia, Randwick, New South Wales, 2031, Australia.; School of Psychiatry, University of New South Wales, Sydney, 2052, Australia.
Fall K; Unit of Integrative Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, SE-171 77, Stockholm, Sweden.; Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, SE-701 82, Örebro, Sweden.
Valdimarsdottir U; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, SE-171 77, Stockholm, Sweden.; Center of Public Health Sciences, University of Iceland, IS-101, Reykjavik, Iceland.; Department of Epidemiology, Harvard T. H. Chan. School of Public Health, Boston, MA, 02115, USA.
Sparén P; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, SE-171 77, Stockholm, Sweden.
Smedby KE; Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, SE-171 77, Stockholm, Sweden.; Center for Hematology, Karolinska University Hospital, SE-171 77, Stockholm, Sweden.
Fang F; Unit of Integrative Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, SE-171 77, Stockholm, Sweden.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2022 Jan 17; Vol. 22 (1), pp. 75. Date of Electronic Publication: 2022 Jan 17.
Typ publikacji:
Journal Article
MeSH Terms:
Anti-Inflammatory Agents, Non-Steroidal/*therapeutic use
Aspirin/*therapeutic use
Drug Prescriptions/*statistics & numerical data
Mortality, Premature/*trends
Neoplasms/*mortality
Accidents/mortality ; Aged ; Cause of Death ; Female ; Humans ; Male ; Middle Aged ; Proportional Hazards Models ; Registries ; Suicide/statistics & numerical data ; Sweden
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies